1. Home
  2. MTEX vs MBRX Comparison

MTEX vs MBRX Comparison

Compare MTEX & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mannatech Incorporated

MTEX

Mannatech Incorporated

HOLD

Current Price

$4.79

Market Cap

10.0M

Sector

Health Care

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$0.41

Market Cap

9.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTEX
MBRX
Founded
1993
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
9.6M
IPO Year
1998
2016

Fundamental Metrics

Financial Performance
Metric
MTEX
MBRX
Price
$4.79
$0.41
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$61.00
AVG Volume (30 Days)
6.9K
1.7M
Earning Date
04-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.49
N/A
Revenue
$108,038,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.80
$0.16
52 Week High
$12.45
$7.98

Technical Indicators

Market Signals
Indicator
MTEX
MBRX
Relative Strength Index (RSI) 54.31 16.60
Support Level $4.01 $0.35
Resistance Level $5.76 $0.57
Average True Range (ATR) 0.48 0.22
MACD 0.07 -0.17
Stochastic Oscillator 74.19 10.65

Price Performance

Historical Comparison
MTEX
MBRX

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Share on Social Networks: